Global proteome analysis identifies active immunoproteasome subunits in human platelets

Molecular and Cellular Proteomics

Volumn 13, Issue 12, 2014, Pages 3308-3319

  Klockenbusch, Cordula ^a   Walsh, Geraldine M ^a,b   Brown, Lyda M ^a   Hoffman, Michael D ^a   Ignatchenko, Vladimir ^c   Kislinger, Thomas ^c,d   Kast, Juergen ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOPROTEASOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEOME; UNCLASSIFIED DRUG; ATP DEPENDENT 26S PROTEASE; HLA ANTIGEN CLASS 1; PROTEIN SUBUNIT;

ARTICLE; CATALYSIS; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE SYSTEM; JURKAT CELL LINE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEOMICS; THROMBOCYTE; THROMBOCYTE FUNCTION; CHEMISTRY; DATA MINING; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOLECULAR GENETICS; PRIMARY CELL CULTURE; PROTEIN SUBUNIT; TUMOR CELL LINE;

BLOOD PLATELETS; CELL LINE, TUMOR; DATA MINING; GENE EXPRESSION; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, INNATE; MOLECULAR SEQUENCE ANNOTATION; PRIMARY CELL CULTURE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; PROTEOME;

EID: 84928252955     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.031757     Document Type: Article

References (56)

1. Weyrich, A. S., Schwertz, H., Kraiss, L. W., and Zimmerman, G. A. (2009) Protein synthesis by platelets: historical and new perspectives. J. Thromb. Haemost. 7, 241-246
2. Landry, P., Plante, I., Ouellet, D. L., Perron, M. P., Rousseau, G., and Provost, P. (2009) Existence of a microRNA pathway in anucleate platelets. Nat. Struct. Mol. Biol. 16, 961-966
3. Semple, J. W., Italiano, J. E., Jr., and Freedman, J. (2011) Platelets and the immune continuum. Nat. Rev. Immunol. 11, 264-274
4. Vieira-de-Abreu, A., Campbell, R. A., Weyrich, A. S., and Zimmerman, G. A. (2012) Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin. Immunopathol. 34, 5-30
5. Weyrich, A., Cipollone, F., Mezzetti, A., and Zimmerman, G. (2007) Platelets in atherothrombosis: new and evolving roles. Curr. Pharm. Des. 13, 1685-1691
6. O'Neill, E. E., Brock, C. J., von Kriegsheim, A. F., Pearce, A. C., Dwek, R. A., Watson, S. P., and Hebestreit, H. F. (2002) Towards complete analysis of the platelet proteome. Proteomics 2, 288-305
7. Garcia, A., Prabhakar, S., Brock, C. J., Pearce, A. C., Dwek, R. A., Watson, S. P., Hebestreit, H. F., and Zitzmann, N. (2004) Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4, 656-668
8. Martens, L., Van Damme, P., Van Damme, J., Staes, A., Timmerman, E., Ghesquiere, B., Thomas, G. R., Vandekerckhove, J., and Gevaert, K. (2005) The human platelet proteome mapped by peptide-centric proteomics: a functional protein profile. Proteomics 5, 3193-3204
9. Thon, J. N., Schubert, P., Duguay, M., Serrano, K., Lin, S., Kast, J., and Devine, D. V. (2008) Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 48, 425-435
10. Krishnan, S., Gaspari, M., Della Corte, A., Bianchi, P., Crescente, M., Cerletti, C., Torella, D., Indolfi, C., de Gaetano, G., Donati, M. B., Rotilio, D., and Cuda, G. (2011) OFFgel-based multidimensional LC-MS/MS approach to the cataloging of the human platelet proteome for an interactomic profile. Electrophoresis 32, 686-695
11. Burkhart, J. M., Vaudel, M., Gambaryan, S., Radau, S., Walter, U., Martens, L., Geiger, J., Sickmann, A., and Zahedi, R. P. (2012) The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 120, e73-82
12. Piersma, S. R., Broxterman, H. J., Kapci, M., de Haas, R. R., Hoekman, K., Verheul, H. M., and Jimenez, C. R. (2009) Proteomics of the TRAP-induced platelet releasate. J. Proteomics 72, 91-109
13. Maguire, P. B., Wynne, K. J., Harney, D. F., O'Donoghue, N. M., Stephens, G., and Fitzgerald, D. J. (2002) Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics 2, 642-648
14. Lewandrowski, U., Wortelkamp, S., Lohrig, K., Zahedi, R. P., Wolters, D. A., Walter, U., and Sickmann, A. (2009) Platelet membrane proteomics: a novel repository for functional research. Blood 114, e10-19
15. Maynard, D. M., Heijnen, H. F., Horne, M. K., White, J. G., and Gahl, W. A. (2007) Proteomic analysis of platelet alpha-granules using mass spectrometry. J. Thromb. Haemost. 5, 1945-1955
16. Zahedi, R. P., Lewandrowski, U., Wiesner, J., Wortelkamp, S., Moebius, J., Schutz, C., Walter, U., Gambaryan, S., and Sickmann, A. (2008) Phosphoproteome of resting human platelets. J. Proteome Res. 7, 526-534
17. Garcia, A., Prabhakar, S., Hughan, S., Anderson, T. W., Brock, C. J., Pearce, A. C., Dwek, R. A., Watson, S. P., Hebestreit, H. F., and Zitzmann, N. (2004) Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood 103, 2088-2095
18. Garcia, A., Senis, Y. A., Antrobus, R., Hughes, C. E., Dwek, R. A., Watson, S. P., and Zitzmann, N. (2006) A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 6, 5332-5343
19. Senis, Y. A., Antrobus, R., Severin, S., Parguina, A. F., Rosa, I., Zitzmann, N., Watson, S. P., and Garcia, A. (2009) Proteomic analysis of integrin alphaIIbbeta3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions. J. Thromb. Haemost. 7, 1718-1726
20. Wright, B., Stanley, R. G., Kaiser, W. J., Mills, D. J., and Gibbins, J. M. (2011) Analysis of protein networks in resting and collagen receptor (GPVI)-stimulated platelet sub-proteomes. Proteomics 11, 4588-4592
21. Parguina, A. F., Alonso, J., Rosa, I., Velez, P., Gonzalez-Lopez, M. J., Guitian, E., Ebble, J. A., Loza, M. I., and Garcia, A. (2012) A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: implications for CLEC-2 signaling regulation. Blood 120, e117-126
22. Ostrowska, H., Ostrowska, J. K., Worowski, K., and Radziwon, P. (2003) Human platelet 20S proteasome: inhibition of its chymotrypsin-like activity and identification of the proteasome activator PA28. A preliminary report. Platelets 14, 151-157
23. Nayak, M. K., Kumar, K., and Dash, D. (2011) Regulation of proteasome activity in activated human platelets. Cell Calcium 49, 226-232
24. Kloetzel, P. M., and Ossendorp, F. (2004) Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr. Opin. Immunol. 16, 76-81
25. Hoffman, M. D., Walsh, G. M., Rogalski, J. C., and Kast, J. (2009) Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method. Mol. Cell. Proteomics 8, 887-903
26. Craig, R., and Beavis, R. C. (2003) A method for reducing the time required to match protein sequences with tandem mass spectra. Rapid Commun. Mass Spectrom. 17, 2310-2316
27. Fenyo, D., and Beavis, R. C. (2003) A method for assessing the statistical significance of mass spectrometry-based protein identifications using general scoring schemes. Anal. Chem. 75, 768-774
28. Ducoux-Petit, M., Uttenweiler-Joseph, S., Brichory, F., Bousquet-Dubouch, M. P., Burlet-Schiltz, O., Haeuw, J. F., and Monsarrat, B. (2008) Scaled-down purification protocol to access proteomic analysis of 20S proteasome from human tissue samples: comparison of normal and tumor colorectal cells. J. Proteome Res. 7, 2852-2859
29. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567
30. Florea, B. I., Verdoes, M., Li, N., van der Linden, W. A., Geurink, P. P., van den Elst, H., Hofmann, T., de Ru, A., van Veelen, P. A., Tanaka, K., Sasaki, K., Murata, S., den Dulk, H., Brouwer, J., Ossendorp, F. A., Kisselev, A. F., and Overkleeft, H. S. (2010) Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit beta5t. Chem. Biol. 17, 795-801
31. Kanehisa, M., and Goto, S. (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27-30
32. Kanehisa, M., Goto, S., Hattori, M., Aoki-Kinoshita, K. F., Itoh, M., Kawashima, S., Katayama, T., Araki, M., and Hirakawa, M. (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 34, D354-D357
33. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., and Hirakawa, M. (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38, D355-D360
34. Yewdell, J. W. (2005) Immunoproteasomes: regulating the regulator. Proc. Natl. Acad. Sci. U.S.A. 102, 9089-9090
35. Brophy, T. M., Raab, M., Daxecker, H., Culligan, K. G., Lehmann, I., Chubb, A. J., Treumann, A., and Moran, N. (2008) RN181, a novel ubiquitin E3 ligase that interacts with the KVGFFKR motif of platelet integrin alpha-(IIb)beta3. Biochem. Biophys. Res. Commun. 369, 1088-1093
36. Dangelmaier, C. A., Quinter, P. G., Jin, J., Tsygankov, A. Y., Kunapuli, S. P., and Daniel, J. L. (2005) Rapid ubiquitination of Syk following GPVI activation in platelets. Blood 105, 3918-3924
37. Yukawa, M., Sakon, M., Kambayashi, J., Shiba, E., Kawasaki, T., Ariyoshi, H., and Mori, T. (1991) Proteasome and its novel endogeneous activator in human platelets. Biochem. Biophys. Res. Commun. 178, 256-262
38. Yukawa, M., Sakon, M., Kambayashi, J., Shiba, E., Kawasaki, T., Uemura, Y., Murata, K., Tanaka, T., Nakayama, T., Shibata, H., and Mori, T. (1993) Purification and characterization of endogenous protein activator of human platelet proteasome. J. Biochem. 114, 317-323
39. Verdoes, M., Florea, B. I., Menendez-Benito, V., Maynard, C. J., Witte, M. D., van der Linden, W. A., van den Nieuwendijk, A. M., Hofmann, T., Berkers, C. R., van Leeuwen, F. W., Groothuis, T. A., Leeuwenburgh, M. A., Ovaa, H., Neefjes, J. J., Filippov, D. V., van der Marel, G. A., Dantuma, N. P., and Overkleeft, H. S. (2006) A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. Chem. Biol. 13, 1217-1226
40. Gu, C., Kolodziejek, I., Misas-Villamil, J., Shindo, T., Colby, T., Verdoes, M., Richau, K. H., Schmidt, J., Overkleeft, H. S., and van der Hoorn, R. A. (2010) Proteasome activity profiling: a simple, robust and versatile method revealing subunit-selective inhibitors and cytoplasmic, defenseinduced proteasome activities. Plant J. 62, 160-170
41. Claverol, S., Burlet-Schiltz, O., Girbal-Neuhauser, E., Gairin, J. E., and Monsarrat, B. (2002) Mapping and structural dissection of human 20 S proteasome using proteomic approaches. Mol. Cell. Proteomics 1, 567-578
42. Groettrup, M., Khan, S., Schwarz, K., and Schmidtke, G. (2001) Interferongamma inducible exchanges of 20S proteasome active site subunits: why? Biochimie 83, 367-372
43. Guillaume, B., Chapiro, J., Stroobant, V., Colau, D., Van Holle, B., Parvizi, G., Bousquet-Dubouch, M. P., Theate, I., Parmentier, N., and Van den Eynde, B. J. (2010) Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proc. Natl. Acad. Sci. U.S.A. 107, 18599-18604
44. Banfi, C., Brioschi, M., Marenzi, G., De Metrio, M., Camera, M., Mussoni, L., and Tremoli, E. (2010) Proteome of platelets in patients with coronary artery disease. Exp. Hematol. 38, 341-350
45. Lopez-Farre, A. J., Zamorano-Leon, J. J., Azcona, L., Modrego, J., Mateos-Caceres, P. J., Gonzalez-Armengol, J., Villarroel, P., Moreno-Herrero, R., Rodriguez-Sierra, P., Segura, A., Tamargo, J., and Macaya, C. (2011) Proteomic changes related to "bewildered" circulating platelets in the acute coronary syndrome. Proteomics 11, 3335-3348
46. Santoso, S., Mueller-Eckhardt, G., Kiefel, V., and Mueller-Eckhardt, C. (1986) HLA antigens on platelet membranes. In vitro and in vivo studies. Vox Sang 51, 327-333
47. Giles, C. M., Botto, M., and King, M. J. (1990) A study of HLA (Bg) on red cells and platelets by immunoblotting with monoclonal antibodies. Transfusion 30, 126-132
48. Aslam, R., Speck, E. R., Kim, M., Freedman, J., and Semple, J. W. (2008) Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells. Transfusion 48, 1778-1786
49. Chemali, M., Radtke, K., Desjardins, M., and English, L. (2011) Alternative pathways for MHC class I presentation: a new function for autophagy. Cell Mol. Life Sci. 68, 1533-1541
50. Antczak, A. J., Vieth, J. A., Singh, N., and Worth, R. G. (2011) Internalization of IgG-coated targets results in activation and secretion of soluble CD40 ligand and RANTES by human platelets. Clin. Vaccine Immunol. 18, 210-216
51. Lindemann, S., Tolley, N. D., Dixon, D. A., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A., and Weyrich, A. S. (2001) Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J. Cell Biol. 154, 485-490
52. Andonegui, G., Kerfoot, S. M., McNagny, K., Ebbert, K. V., Patel, K. D., and Kubes, P. (2005) Platelets express functional Toll-like receptor-4. Blood 106, 2417-2423
53. Singh, A. V., Bandi, M., Aujay, M. A., Kirk, C. J., Hark, D. E., Raje, N., Chauhan, D., and Anderson, K. C. (2010) PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell growth both in vitro and in vivo. Br. J. Haematol. 152, 155-163
54. Avcu, F., Ural, A. U., Cetin, T., and Nevruz, O. (2008) Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro. Thromb. Res. 121, 567-571
55. Nayak, M. K., Kulkarni, P. P., and Dash, D. (2013) Regulatory role of proteasome in determination of platelet life span. J. Biol. Chem. 288, 6826-6834
56. Kuhn, D. J., Hunsucker, S. A., Chen, Q., Voorhees, P. M., Orlowski, M., and Orlowski, R. Z. (2009) Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors. Blood 113, 4667-4676